Your browser doesn't support javascript.
loading
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations.
Conforti, Fabio; Pala, Laura; Pagan, Eleonora; Rocco, Elena Guerini; Bagnardi, Vincenzo; Montagna, Emilia; Peruzzotti, Giulia; De Pas, Tommaso; Fumagalli, Caterina; Pileggi, Silvana; Pesenti, Chiara; Marchini, Sergio; Corso, Giovanni; Marchio', Caterina; Sapino, Anna; Graffeo, Rossella; Collet, Laetitia; Aftimos, Philippe; Sotiriou, Christos; Piccart, Martine; Gelber, Richard D; Viale, Giuseppe; Colleoni, Marco; Goldhirsch, Aron.
Affiliation
  • Conforti F; Division of Medical Oncology for Melanoma & Sarcoma, IEO, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: fabio.conforti@ieo.it.
  • Pala L; Division of Medical Oncology for Melanoma & Sarcoma, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Pagan E; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
  • Rocco EG; Division of Pathology, IEO, European Institute of Oncology, IRCCS, Milano, Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Bagnardi V; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
  • Montagna E; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Peruzzotti G; Division of Data Management, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • De Pas T; Division of Medical Oncology for Melanoma & Sarcoma, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Fumagalli C; Division of Pathology, IEO, European Institute of Oncology, IRCCS, Milano, Italy.
  • Pileggi S; Department of Oncology, Mario Negri Institute for Pharmacological Research, IRCCS, Italy.
  • Pesenti C; Department of Oncology, Mario Negri Institute for Pharmacological Research, IRCCS, Italy.
  • Marchini S; Department of Oncology, Mario Negri Institute for Pharmacological Research, IRCCS, Italy.
  • Corso G; Division of Senology, European Institute of Oncology, IRCCS, Milan, Italy.
  • Marchio' C; Department of Medical Sciences, University of Torino, Turin, Italy; Unit of Pathology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo, TO, Italy.
  • Sapino A; Department of Medical Sciences, University of Torino, Turin, Italy; Unit of Pathology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo, TO, Italy.
  • Graffeo R; High Risk Clinic, Oncological Genetics Service, Oncology Institute of Southern Switzerland, Ospedale Italiano, Lugano, Switzerland.
  • Collet L; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Aftimos P; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Sotiriou C; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Piccart M; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Gelber RD; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Frontier Science & Technology Research Foundation, Boston, USA.
  • Viale G; Department of Pathology, IEO, European Institute of Oncology IRCCS & State University of Milan, Milan, Italy.
  • Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Goldhirsch A; MultiMedica San Giuseppe Hospital, Milan, Italy.
Breast ; 59: 94-101, 2021 Oct.
Article in En | MEDLINE | ID: mdl-34217971

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Carcinoma, Lobular Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Breast Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Carcinoma, Lobular Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Breast Year: 2021 Document type: Article